USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
VINDICO NANOBIOTECHNOLOGY, INC.
Address:
A169, ASTeCC Bldg.,145 Graham Avenue
LEXINGTON, KY 40506-0286
Phone:
N/A
URL:
EIN:
126139759
DUNS:
808379072
Number of Employees:
3
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $899,888.00 2

Award List:

A transfollicular nanovaccine against leishmaniasis

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$600,000.00
Agency:
HHS
Principal Investigator:
Paiman P. Ghoroghchian – 267-259-1086
Abstract:
DESCRIPTION (provided by applicant): The World Health Organization estimates that over 350 million people are at risk of developing leishmaniasis and infection prevalence is 14 million people in the world. Annually, 2 million people are infected with Leishmania species and 270,000 will die.… More

Modulation of In Vivo Tumor Oxygenation via Polymersome-encapsulated Myoglobin

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$299,888.00
Agency:
HHS
Principal Investigator:
Paiman P. Ghoroghchian – 267-496-3625
Abstract:
DESCRIPTION (provided by applicant): Over 250,000 new cases of head and neck cancers (HNCs) and non-small cell lung cancers (NSCLCs) are diagnosed every year in the United States. At the time of diagnosis, 60% of these cases are regionally advanced (stageIII and IV). Wide surgical excision is not… More